Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer

NCT00549822 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Breast Cancer

Interventions

DRUG: Letrozole

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]